首页> 外文期刊>RSC Advances >Multiple cross-linked hydroxypropylcellulose-succinate-salicylate: prodrug design, characterization, stimuli responsive swelling-deswelling and sustained drug release
【24h】

Multiple cross-linked hydroxypropylcellulose-succinate-salicylate: prodrug design, characterization, stimuli responsive swelling-deswelling and sustained drug release

机译:多种交联的羟丙基纤维素-琥珀酸酯-水杨酸酯:前药设计,表征,刺激性溶胀消肿和持续药物释放

获取原文
获取原文并翻译 | 示例
           

摘要

A hydroxypropylcellulose-succinic anhydride (HPC-SAn) conjugate was synthesized homogeneously at 80 degrees C for 6 h under N-2 in N, N-dimethylacetamide (DMA). The HPC-SAn conjugate was further covalently linked with salicylic acid (SA) drug using the versatile reagent ZrOCl2 center dot 8H(2)O at 80 degrees C for 6 h. Multiple crosslinking of the benign HPC-SAn-SA conjugate was achieved using oxalyl chloride. The resultant cross-linked prodrug (CL-HPC-SAn-SA conjugate) was characterized using different spectroscopic techniques. UV/Vis analysis of the HPC-SAn-SA conjugate has indicated that it contains 26 mg of SA per 100 mg. CL-HPC-SAn-SA showed reasonably good swelling properties in water and at different physiological pH values (6.8 and 7.4). However, negligible swelling was observed at acidic pH (1.2). Kinetic studies revealed that CL-HPC-SAn-SA followed second order swelling kinetics. Additionally, the CL-HPC-SAn-SA conjugate showed stimuli responsive (pH 7.4/1.2) swelling-deswelling properties. The effect of different pH values (1-10) on the swelling of CL-HPCSAn- SA was also studied. Thermal analysis revealed that the cross-linked prodrug CL-HPC-SAn-SA was thermally more stable compared to pure SA. This method of multiple crosslinking of drugs with polysaccharides and the resultant prodrugs has a high potential for pharmaceutical and medicinal applications.
机译:在N,N-二甲基乙酰胺(DMA)中,在N-2下,在80摄氏度下均匀合成羟丙基纤维素-琥珀酸酐(HPC-SAn)共轭物6小时。使用多功能试剂ZrOCl2中心点8H(2)O在80摄氏度下将HPC-SAn共轭物与水杨酸(SA)药物进一步共价连接6小时。使用草酰氯可实现良性HPC-SAn-SA共轭物的多重交联。使用不同的光谱技术表征所得的交联前药(CL-HPC-SAn-SA共轭物)。 HPC-SAn-SA共轭物的UV / Vis分析表明,每100 mg含有26 mg SA。 CL-HPC-SAn-SA在水中和不同的生理pH值(6.8和7.4)下显示出相当好的溶胀性能。但是,在酸性pH(1.2)下观察到的溶胀可忽略不计。动力学研究表明,CL-HPC-SAn-SA遵循二级溶胀动力学。另外,CL-HPC-SAn-SA共轭物表现出刺激响应性(pH 7.4 / 1.2)溶胀-溶胀特性。还研究了不同pH值(1-10)对CL-HPCSAn-SA溶胀的影响。热分析显示,与纯SA相比,交联前药CL-HPC-SAn-SA在热方面更稳定。药物与多糖和所得前药的多重交联的这种方法在药物和医学应用中具有很高的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号